27Apr
[Video] Six Things You Need to Know About Life Sciences M&A During and After COVID-19
While life sciences M&A activity soared to a new high in 2019, the uncertainty surrounding the pandemic has led to a slow down in deal making activity. However, as the crisis in the U.S. subsides and the U.S. economy stabilizes, we expect life...
By:
Arnall Golden Gregory LLP
Related
On January 9, 2020, the Iowa Court of Appeals released two opinions – Dix v. Casey’s General Store...
Read More >
While the gig economy often gets derided by worker advocates for being unfair to its workers, one as...
Read More >
A recent Pennsylvania case provides a good reminder that retaliation claims can arise long after an ...
Read More >
Fifth Wall to launch PropTech SPAC - The Real Deal – January 6 - Fifth Wall, a prolific PropTec...
Read More >
On December 6, 2019, USCIS announced it is implementing the registration process in the next H-1B lo...
Read More >
On December 31, 2020, Vice Chancellor Glasscock issued an opinion regarding what he called a “novel...
Read More >